Brompheniramine
Substituted Alkylamines
- Drug class
- Substituted Alkylamines
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 8
Overview
Plain-language summary, compiled from the cited regulatory records
Brompheniramine is an active pharmaceutical ingredient classified as a substituted alkylamine [1]. It is approved for the relief of coughs and upper respiratory symptoms, such as nasal congestion, that are associated with allergies or the common cold [1].
This ingredient is available under various brand names in the market [1]. In the past 12 months, there have been 8 adverse event reports concerning brompheniramine [2]. The most frequently reported adverse events include anxiety, aphthous ulcer, arthralgia, bronchitis, and cough [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | January 2, 2026 |
USUnited States· FDA
1 product
Uses
INDICATIONS & USAGE
For relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.
How to take
Drug interactions
Known interactions involving Brompheniramine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 268. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 036b587a-7bfe-41… · revised January 2, 2026 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.